Home › NDC Lookup › Ingredients › Tamsulosin Hydrochloride › 65862-0598-01
💊image loading
(from DailyMed)

Tamsulosin Hydrochloride .4 mg Capsule, 100-count — NDC 65862-598-01 (Billing 65862-0598-01)

by Aurobindo Pharma Limited · 100 CAPSULE in 1 BOTTLE

This is a package of 100 capsules of Tamsulosin Hydrochloride .4 mg Capsule from Aurobindo Pharma Limited, marketed since Apr 2013 and currently FDA-listed; retail pharmacies pay about $0.0500 per capsule (NADAC).

NDC 65862-0598-01
🏷️ FDA NDC (as labeled) 65862-598-01 billing pads the product segment with a zero
This package
Contains100-count Cost per ea$0.0500 NADAC Per package$5.00 / 100 capsules Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.2505/unit · Part D plans $0.1304/unit — full pricing hub ↓
Product page 65862-0598-05 Also comes in: 30 capsules 65862-598-10 500 capsules 65862-598-05 2000 capsules 65862-598-22
On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 65862-598-01 alone.

Record
FDA NDC Directory package listing · Drug for further processing
Code segments
65862 labeler · 598 product · 01 package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 6586259801 1
Medicaid fills, this package
45,084 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65862-598-01
Product NDC 65862-598
11-digit billing NDC 65862059801
NCPDP billing unit EA — each (per item)
SPL Set ID 4f9f7a9e-037b-47bf-ad38-5fca18d93b6d
DEA schedule Non-controlled
Marketing category DRUG FOR FURTHER PROCESSING
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-04-30
Dosage form CAPSULE
Substance TAMSULOSIN HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 56852070100110
GPI class Tamsulosin HCl
GCN Seq No 027546
GCN 48191
HICL code 013864
Ingredient (HICL) Tamsulosin Hcl
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q9
Therapeutic class — intermediate (HIC2) Urological Preparations
HIC3 code Q9B
Therapeutic class — specific (HIC3) Benign Prostatic Hypertrophy/Micturition Agents
AHFS code 12:16.04.12
AHFS class Selective Alpha-1-Adrenergic Block.agent
FDB label name TAMSULOSIN HCL 0.4 MG CAPSULE
FDB brand name Tamsulosin Hcl
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 027546
  • GCN: 48191
  • GPI-14 (Medi-Span): 56852070100110
  • HICL (First Databank): 013864
  • AHFS class code: 12:16.04.12
Why two NDCs? The FDA registers this code as 65862-598-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65862-0598-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name TAMSULOSIN HCL 0.4 MG CAPSULE Ingredient Tamsulosin Hcl
📖 What it is MedlinePlus · NLM

Tamsulosin is used to treat benign prostatic hyperplasia (BPH; enlarged prostate that can cause difficulty urinating, painful urination or increased urinary frequency or urgency). Tamsulosin is in a class of medications called alpha blockers. It works by relaxing the muscles in the prostate and bladder so that urine can flow easily.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • Tamsulosin is designed to ease the urinary symptoms caused by an enlarged prostate — things like a weak stream, straining to start, or feeling like you haven't fully emptied your b...
  • What exactly is tamsulosin supposed to do for me?
  • Take it once a day, about 30 minutes after the same meal each day — for example, every morning after breakfast. Consistency matters here. Swallow the capsule whole; don't crush, ch...
  • It can, yes — this is one of the more common side effects, and it's worth knowing about upfront. Some men notice reduced ejaculation volume or what's called retrograde ejaculation,...
📖 Read our full Tamsulosin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.050 $5.00 / 100 capsules
Medicaid paysCMS SDUD · 12 mo $0.2505 $25.05 / 100 capsules
Medicare drug plans payPart D · Q2 2026 $0.1304 $13.04 / 100 capsules
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.065 $0.049
▼ Down 19% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
65862-0598-01 You're viewing this 100 CAPSULE in 1 BOTTLE $0.0500 / ea $5.00 2013-04-30 — Active
65862-0598-05 65862-598-05 Main listing 500 CAPSULE in 1 BOTTLE $0.0500 / ea $24.99 2013-04-30 — Active
65862-0598-10 65862-598-10 3 BLISTER PACK in 1 CARTON / 10 CAPSULE in 1 BLISTER PACK — — 2013-04-30 — Active
65862-0598-22 65862-598-22 2000 CAPSULE in 1 BAG — — — — Active

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.0500 NADAC).

This pack accounts for about 5.1% of this product's recent Medicaid fills; most go to the 500 capsules pack. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 capsule in 1 bottle.
How does this package differ from NDC 65862-0598-10?
Both are Tamsulosin Hydrochloride .4 mg Capsule — the drug itself is identical. This page's package is the 100-count one, while NDC 65862-0598-10 is the 30 capsules package.
What NDC number is used to bill for this package of Tamsulosin Hydrochloride .4 mg Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Tamsulosin Hydrochloride .4 mg 00904-7383-61 Major 100 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 50268-0740-15 AvPAK 50 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 57237-0014-01 Rising 100 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 62135-0775-30 Chartwell 30 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mgthis 65862-0598-01 Aurobindo 100 capsules $0.050 — Availability likely —
Tamsulosin Hydrochloride .4 mg 67877-0450-01 Ascend 100 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 68084-0299-01 American 100 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 68382-0132-01 Zydus 100 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 72603-0115-01 NorthStar 100 capsules $0.050 AB Availability likely —
Tamsulosin hydrochloride .4 mg 76282-0744-05 EXELAN 500 capsules $0.050 AB Availability likely —
Tamsulosin Hydrochloride .4 mg 82009-0025-10 Quallent 1000 capsules $0.050 AB Availability likely —
tamsulosin hydrochloride .4 mg 00781-2076-01 Sandoz 100 capsules $0.054 — FDA listed +8%
Tamsulosin Hydrochloride .4 mg 00115-8211-01 Amneal 100 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 00615-8055-05 NCS 15 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 33342-0159-07 Macleods 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 42291-0989-10 AvKARE 1000 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 43063-0725-30 PD-Rx 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 43063-0947-30 PD-Rx 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 50090-1846-00 A-S 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 50090-3646-00 A-S 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 50090-4906-00 A-S 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 50090-5553-00 A-S 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 50090-6699-00 A-S 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 50090-6700-00 A-S 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 51407-0879-90 Golden 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 51655-0832-52 Northwind 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 55154-2142-00 Cardinal 10 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 55154-2636-00 Cardinal 10 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 60760-0598-90 St. 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 61919-0703-90 DIRECT 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 62756-0160-08 Sun 100 capsules — — FDA listed —
Tamsulosin Hydrochloride .4 mg 63187-0358-07 Proficient 7 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 63187-0371-07 Proficient 7 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 63187-0469-30 Proficient 30 capsules — — FDA listed —
Tamsulosin Hydrochloride .4 mg 63629-4346-01 Bryant 30 capsules — AB FDA listed —
Tamsulosin hydrochloride .4 mg 63672-0021-09 Synthon 20000 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 65841-0695-01 Zydus 100 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 67046-1015-03 Coupler 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 67296-2220-01 Redpharm 7 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 68071-1840-01 NuCare 100 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 68071-2561-01 NuCare 10 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 68071-4443-01 NuCare 10 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 68071-4872-09 NuCare 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 68071-5118-01 NuCare 100 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 68788-7050-01 Preferred 100 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 70518-0179-00 REMEDYREPACK 30 capsules — AB Discontinued —
Tamsulosin Hydrochloride .4 mg 70518-2052-00 REMEDYREPACK 90 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71205-0217-07 Proficient 7 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71205-0688-07 Proficient 7 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71335-0398-01 Bryant 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71335-1538-01 Bryant 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71335-1784-01 Bryant 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71610-0724-30 Aphena 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71610-0738-30 Aphena 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 71610-0835-30 Aphena 30 capsules — AB FDA listed —
Tamsulosin hydrochloride .4 mg 71610-0910-30 Aphena 30 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 72162-2217-05 Bryant 500 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 72162-2502-00 Bryant 1000 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 72162-2509-01 Bryant 100 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 72865-0282-01 XLCare 100 capsules — AB FDA listed —
tamsulosin hydrochloride .4 mg 72865-0350-05 XLCare 500 capsules — AB FDA listed —
Tamsulosin Hydrochloride .4 mg 43579-0011-98 Synthon 20000 capsules — — FDA listed —
tamsulosin hydrochloride .4 mg 49629-0011-99 Rottendorf 1440000 capsules — — FDA listed —
Tamsulosin Hydrochloride .4 mg 68788-4145-01 Preferred 100 capsules — AB FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Apr 2013
📍
2026
Currently FDA-listed
13 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Tamsulosin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Labeler code65862
First marketedApr 2013
Product typeDrug For Further Processing
Portfolio1,464 products on file

More NDCs from Aurobindo Pharma Limited labeler code 65862

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full FDA label FDA SPL

The complete FDA label for this product, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
45.1K
Units reimbursed last 4 qtrs
2.1M
Gross reimbursed last 4 qtrs
$514.9K
Avg / prescription
$11.42
Avg / unit
$0.2505
Latest quarter Q4 2025
10.2KRx
Medicaid pays / ea
$0.2505
gross reimbursed
vs
NADAC / ea
$0.0500
acquisition cost
=
Spread
+$0.2005
+401% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
48% FFS 52% MCO
Fee-for-service · 21,651 Rx Managed care · 23,433 Rx
State Medicaid map
Alaska: 6,759 units · 922 per 100k residents AK Maine: 3,751 units · 269 per 100k residents ME Washington: 44,232 units · 566 per 100k residents WA Idaho: 6,135 units · 312 per 100k residents ID Montana: 6,549 units · 579 per 100k residents MT North Dakota: 2,911 units · 372 per 100k residents ND Minnesota: 22,184 units · 387 per 100k residents MN Wisconsin: 37,596 units · 636 per 100k residents WI Michigan: 62,197 units · 620 per 100k residents MI New York: 499,449 units · 2,552 per 100k residents NY Vermont: 12,997 units · 2,009 per 100k residents VT New Hampshire: 3,953 units · 282 per 100k residents NH Oregon: 34,627 units · 818 per 100k residents OR Nevada: 8,360 units · 262 per 100k residents NV Wyoming: no data reported WY South Dakota: 3,807 units · 414 per 100k residents SD Iowa: 20,173 units · 629 per 100k residents IA Illinois: 55,373 units · 441 per 100k residents IL Indiana: 19,788 units · 288 per 100k residents IN Ohio: 75,737 units · 643 per 100k residents OH Pennsylvania: 116,010 units · 895 per 100k residents PA New Jersey: 35,436 units · 381 per 100k residents NJ Massachusetts: 31,987 units · 457 per 100k residents MA California: 231,953 units · 595 per 100k residents CA Utah: 2,143 units · 62.7 per 100k residents UT Colorado: 19,683 units · 335 per 100k residents CO Nebraska: 3,890 units · 197 per 100k residents NE Missouri: 49,828 units · 804 per 100k residents MO Kentucky: 57,201 units · 1,264 per 100k residents KY West Virginia: 43,330 units · 2,448 per 100k residents WV Virginia: 34,289 units · 393 per 100k residents VA Maryland: 70,091 units · 1,134 per 100k residents MD Connecticut: 31,016 units · 858 per 100k residents CT Rhode Island: 440 units · 40.2 per 100k residents RI Arizona: 26,872 units · 362 per 100k residents AZ New Mexico: 7,132 units · 337 per 100k residents NM Kansas: 4,240 units · 144 per 100k residents KS Arkansas: 11,871 units · 387 per 100k residents AR Tennessee: 13,673 units · 192 per 100k residents TN North Carolina: 36,282 units · 335 per 100k residents NC South Carolina: 3,444 units · 64.1 per 100k residents SC Delaware: 4,416 units · 428 per 100k residents DE Oklahoma: 43,005 units · 1,061 per 100k residents OK Louisiana: 41,300 units · 903 per 100k residents LA Mississippi: 10,397 units · 354 per 100k residents MS Alabama: 8,531 units · 167 per 100k residents AL Georgia: 15,392 units · 140 per 100k residents GA D.C.: 15,485 units · 2,281 per 100k residents DC Hawaii: 10,318 units · 719 per 100k residents HI Texas: 25,141 units · 82.4 per 100k residents TX Florida: 35,007 units · 155 per 100k residents FL
Units reimbursed · per 100k residents
40.22,552
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 New York 2,552 /100k
2 West Virginia 2,448 /100k
3 D.C. 2,281 /100k
4 Vermont 2,009 /100k
5 Kentucky 1,264 /100k
6 Maryland 1,134 /100k
7 Oklahoma 1,061 /100k
8 Alaska 922 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
500 capsules65862-0598-05 812,123 Rx · $8,382,209
100 capsules this page65862-0598-01 43,369 Rx · $483,475
30 capsules65862-0598-10 No Medicaid data
2000 capsules65862-0598-22 No Medicaid data
Drug total (last 4 qtrs): 855,492 Rx · 36,840,530 units · $8,865,684 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

About this NDC listing & data coverage

Listed for further processing / repackaging

What "drug for further processing" means

FDA lists this package under the "drug for further processing" marketing category: Aurobindo Pharma Limited supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) ✓ Available
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) ✓ Available
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Drug For Further Processing". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Aurobindo Pharma Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 30 capsules (65862-0598-10), 500 capsules (65862-0598-05), 2000 capsules (65862-0598-22). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Aurobindo Pharma Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 65862-0596-01 · Aurobindo 65862-0599-12 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.